Zomedica Pharmaceuticals Stock Forecast - 20 Period Moving Average
| ZOM Stock | USD 0.12 0.01 7.69% |
The 20 Period Moving Average forecasted value of Zomedica Pharmaceuticals Corp on the next trading day is expected to be 0.13 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.26. Zomedica Stock Forecast is based on your current time horizon. Although Zomedica Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Zomedica Pharmaceuticals' systematic risk associated with finding meaningful patterns of Zomedica Pharmaceuticals fundamentals over time.
Zomedica |
Zomedica Pharmaceuticals 20 Period Moving Average Price Forecast For the 12th of December 2024
Given 90 days horizon, the 20 Period Moving Average forecasted value of Zomedica Pharmaceuticals Corp on the next trading day is expected to be 0.13 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.000072, and the sum of the absolute errors of 0.26.Please note that although there have been many attempts to predict Zomedica Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Zomedica Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Zomedica Pharmaceuticals Stock Forecast Pattern
| Backtest Zomedica Pharmaceuticals | Zomedica Pharmaceuticals Price Prediction | Buy or Sell Advice |
Zomedica Pharmaceuticals Forecasted Value
In the context of forecasting Zomedica Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Zomedica Pharmaceuticals' downside and upside margins for the forecasting period are 0 and 4.15, respectively. We have considered Zomedica Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Zomedica Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Zomedica Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 73.6536 |
| Bias | Arithmetic mean of the errors | 8.0E-4 |
| MAD | Mean absolute deviation | 0.0062 |
| MAPE | Mean absolute percentage error | 0.0481 |
| SAE | Sum of the absolute errors | 0.2585 |
Predictive Modules for Zomedica Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zomedica Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Zomedica Pharmaceuticals
For every potential investor in Zomedica, whether a beginner or expert, Zomedica Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Zomedica Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Zomedica. Basic forecasting techniques help filter out the noise by identifying Zomedica Pharmaceuticals' price trends.View Zomedica Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Zomedica Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Zomedica Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Zomedica Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Zomedica Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Zomedica Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zomedica Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Zomedica Pharmaceuticals stock market strength indicators, traders can identify Zomedica Pharmaceuticals Corp entry and exit signals to maximize returns.
| Accumulation Distribution | 265088.0 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.92 | |||
| Day Median Price | 0.13 | |||
| Day Typical Price | 0.12 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
Zomedica Pharmaceuticals Risk Indicators
The analysis of Zomedica Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zomedica Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zomedica stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.76 | |||
| Standard Deviation | 3.93 | |||
| Variance | 15.41 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Zomedica Pharmaceuticals to cross-verify your projections. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.06) | Revenue Per Share 0.027 | Quarterly Revenue Growth 0.018 | Return On Assets (0.09) | Return On Equity (0.24) |
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.